Nordisk Pharma Holding ApS: Financial statements 2025
CVR: 42848840
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nordisk Pharma Holding ApS (CVR 42848840) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 340,000. The solvency ratio was 86.4%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 340,000
- Total Assets
- DKK 393,424
- Employees
- 0
Official annual report
How creditworthy is Nordisk Pharma Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nordisk Pharma Holding ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 0.
About Nordisk Pharma Holding ApS
Nordisk Pharma Holding ApS is a Danish company of the type Anpartsselskab based in Vallensbæk, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Sayed Edris Sadat and Sanad Emad Hussein Al Bidany. The company is owned by Sayed Edris Sadat and Sanad Emad Hussein Al Bidany. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 340,000.
